Deprivation and ethnicity impact on diabetes control and use of treatment regimen

R J Thompson1, K Agostini, L Potts

  • 1Children and Young People's Diabetes Service, University College London Hospitals, London, UK.

Insights

Deprivation and ethnicity significantly impact pediatric diabetes care, affecting insulin therapy choices and glycemic control (HbA1c). Equitable care requires better consideration of diverse ethnic group needs.

Area of Science:

  • Pediatric Endocrinology
  • Health Disparities
  • Diabetes Management

Background:

  • Socioeconomic status and ethnicity can influence healthcare access and outcomes.
  • Understanding these factors is crucial for equitable management of chronic conditions like Type 1 diabetes in children.

Purpose of the Study:

  • To investigate the influence of deprivation and ethnicity on diabetes care delivery in a pediatric clinic.
  • To assess how these factors affect insulin treatment regimens, glycemic control (HbA1c), and service satisfaction.

Main Methods:

  • A cohort of 325 children and young people with Type 1 diabetes were analyzed.
  • Data included insulin treatment type (twice-daily, multiple daily injections, continuous subcutaneous insulin infusion), HbA1c levels, clinic attendance rates, deprivation indices, and ethnicity.
  • Statistical analyses were performed to correlate these variables.

Main Results:

  • Insulin pump therapy (continuous subcutaneous insulin infusion) was associated with lower HbA1c levels.
  • White British and Asian Indian ethnic groups were more likely to receive insulin pump therapy.
  • Deprivation was linked to ethnicity and HbA1c, though clinic attendance was not affected by deprivation.

Conclusions:

  • Deprivation and ethnicity play a significant role in diabetes control and the utilization of intensive insulin therapy in pediatric patients.
  • There is a need for improved consideration of the specific needs of different ethnic groups to ensure equitable diabetes care delivery.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.